Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001376113.1(ZBTB38):c.1372A>G(p.Met458Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
ZBTB38 (HGNC:26636): (zinc finger and BTB domain containing 38) The protein encoded by this gene is a zinc finger transcriptional activator that binds methylated DNA. The encoded protein can form homodimers or heterodimers through the zinc finger domains. In mouse, inhibition of this protein has been associated with apoptosis in some cell types. [provided by RefSeq, Jun 2010]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Dec 08, 2023
The c.1372A>G (p.M458V) alteration is located in exon 8 (coding exon 1) of the ZBTB38 gene. This alteration results from a A to G substitution at nucleotide position 1372, causing the methionine (M) at amino acid position 458 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of catalytic residue at V454 (P = 0.0588);Loss of catalytic residue at V454 (P = 0.0588);Loss of catalytic residue at V454 (P = 0.0588);Loss of catalytic residue at V454 (P = 0.0588);Loss of catalytic residue at V454 (P = 0.0588);Loss of catalytic residue at V454 (P = 0.0588);